miR-23b suppresses lung carcinoma cell proliferation through CCNG1

Oncology Letters
Hongsheng HanXiaoli Cao

Abstract

Lung carcinoma with high incidence rate could be divided into four subtypes, including small cell carcinoma, squamous cell carcinoma, adenocarcinoma and large cell carcinoma. miR-23b has been reported to have a low expression and play major roles in abundant tumors, however there is little research in lung carcinoma and hence the purpose of this study was to explore the impact of miR-23b in lung carcinoma. The RNA level of miR-23b and cyclin G1 (CCNG1) was measured by reverse transcription quantitative PCR. Luciferase activity reporter assay was used to verify that CCNG1 is a target of miR-23b. MTT and Transwell assays were utilized to test the functional studies of miR-23b in lung cancer cells. In lung carcinoma and lung cancer cells miR-23b expression is low compared with that in paracancerous tissues and normal lung cells. Low miR-23b expression inhibited lung cancer cell proliferation measured by MTT assay. We applied luciferase reporter to determine whether CCNG1 is a target of miR-23b and there was a negative correlation between them. Moreover, interference with CCNG1 reduced the cell proliferation ability, which partially reversed function of miR-23b. miR-23b inhibited cell proliferation of lung cancer by directly target...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Sep 17, 2004·Nature·Victor Ambros
Jun 10, 2005·Nature·Jun LuTodd R Golub
Jan 26, 2006·Gene Expression Patterns : GEP·Giuseppina Di GiacomoLicia Selleri
Oct 15, 2008·Nature Reviews. Genetics·Alex S Flynt, Eric C Lai
Feb 26, 2009·Cell·Olivier Voinnet
Jul 10, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C ParisP Hainaut
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marilena V Iorio, Carlo M Croce
Jun 21, 2011·Clinical and Experimental Medicine·Xing-Xing YeCai Zhi-Yi
Jun 28, 2013·Molecular Cancer Therapeutics·Wen WenHong-Yang Wang
Jul 12, 2013·PloS One·Shahana MajidSoichiro Yamamura
Dec 19, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Florentine S B SubtilJörg Hänze
May 16, 2014·World Journal of Clinical Oncology·Gerasimos Socrates Christodoulatos, Maria Dalamaga
Dec 5, 2014·Molecular and Cellular Biochemistry·Xiaoming ZhaoDaotang Li
Mar 26, 2015·Nature·Dominique LauresserguesJean-Philippe Combier
Oct 20, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Xiaogang LiuXiaoyan Wang
Dec 17, 2015·Advances in Experimental Medicine and Biology·Lindsey A TorreAhmedin Jemal
Feb 14, 2016·Journal of Experimental & Clinical Cancer Research : CR·Jing YanZhi-Hong Zong
Mar 7, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jie CaoYiqun Yan
Nov 28, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Ying ZhuWenlei Zhuo
Dec 26, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuan ZhangXing Li
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection
electrophoresis
Assay

Software Mentioned

SPSS
TargetScan

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.